mRNA Synthesis & Manufacturing Market to Hit USD 738.3 Million by 2029 with 3.4% CAGR | MarketsandMarkets | PR Newswire [Video]

, /PRNewswire/ — The global mRNA synthesis and manufacturing market is projected to grow from USD 624.4 million in 2024 to USD 738.3 million by 2029, at a CAGR of 3.4%. Key drivers include the growing focus on mRNA-based vaccines, expanding therapeutic applications, advancements in synthesis technology, and industry collaborations. Challenges such as high production costs, stability, and scalability remain hurdles. The rising demand for personalized medicine, particularly in cancer and rare genetic disorder therapies, is accelerating market growth, with major players like BioNTech and Moderna leading innovations. Artificial intelligence is also transforming the sector, optimizing drug development and manufacturing processes. Key opportunities lie in advancements in drug delivery technologies, while North America remains the largest regional market due to significant investments and mRNA’s proven efficacy in COVID-19 vaccines.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105705347

Browse in-depth TOC on “mRNA Synthesis & Manufacturing Market“

250 – Tables

50 – Figures

250 – Pages

The market is expanding rapidly due to factors such as the development …